Nuclear Imaging Devices Market Strategies, Challenges, Geography Trends, Business Growth, Applications
The global nuclear
imaging devices market is expected to grow significantly over the forecast
period. It is anticipated that the market held a valuation of USD 2490 million
in 2018 and is projected to register a CAGR of 5.2% over the forecast
period.However, the high cost of the nuclear imaging device, shorter half-life
of radiopharmaceuticals can hamper market growth over the forecast period.
The increasing prevalence of cardiovascular disorders is one
of the key factors driving the nuclear imaging devices market. As per the
report published by the Centers for Disease Control and Prevention (CDC) in
2017, nearly 92.1 million adults were dealing with at least one type of
cardiovascular disease.Various other factors such as the advancements in
radiotracers, acceptance of nuclear imaging devices in ambulatory settings,
increasing geriatric population, untapped emerging markets, rise in regulatory
approvals, and increasing investment on diagnostic imaging centers are also
expected to propel the growth of the market.
Key Players
Some of the key players in the global nuclear imaging
devices market are Philips Healthcare, Digirad Corporation, Neusoft Medical
Systems Co., Ltd., Progenics Pharmaceuticals Inc., Cannon Inc., Surgiceye GmbH,
CMR Naviscan, Mediso Medical Imaging Systems Ltd., Agfa-Gevaert Group, General
Electric Company, DDD-Diagnostic A/S, Spectrum Dynamics Medical, FMI Medical
Systems, Inc., Segamicorp, and others.
Request Free Sample Copy at: https://www.marketresearchfuture.com/sample_request/8014
Segmentation
The global nuclear imaging devices market is segmented based
on technology, application, end user, and region.
The global market for nuclear imaging devices, by
technology, is segmented into positron emission tomography (PET), single photon
emission computed tomography (SPECT), and planar scintigraphy. The
single-photon-emission computed tomography (SPECT) are further classified as
hybrid SPECT systems and standalone SPECT systems.
Based on application, the market is segmented into oncology,
cardiology, neurology, and others.
Based on end user, the market is segmented into hospitals,
diagnostic imaging centers, and others.
The diagnostic imaging centers segment is expected to
witness the fastest growth over the forecast period due to rising adoption of
nuclear imaging in diagnostic centers.
Regional Analysis
In the current scope of the study, the segments mentioned
above are covered into the four global regions, namely, the Americas, Europe,
Asia-Pacific, and the Middle East and African region.
The nuclear imaging devices market in the Americas has
further been segmented into North America and South America, with the North
American market divided into the US and Canada.
The European nuclear imaging devices market has been
segmented into Western Europe and Eastern Europe. Western Europe has been
classified as Germany, France, the UK, Italy, Spain, and the rest of Western
Europe. The nuclear imaging devices
market in Asia-Pacific has been segmented into Japan, China, India, South
Korea, Australia, and the rest of Asia-Pacific. The nuclear imaging devices
market in the Middle East & Africa has been segmented into the Middle East
and Africa.
Browse Detailed TOC
with COVID-19 Impact Analysis at: https://www.marketresearchfuture.com/reports/nuclear-imaging-devices-market-8014
About Market
Research Future:
At Market Research
Future (MRFR), we enable our customers to unravel the complexity of various
industries through our Cooked Research Report (CRR), Half-Cooked Research
Reports (HCRR), & Consulting Services. MRFR team have supreme objective to
provide the optimum quality market research and intelligence services to our clients.
Contact:
Akash Anand
Market Research
Future
+1 646 845 9312
Comments
Post a Comment